TAMRO Capital Partners’s Edwards Lifesciences EW Stock Holding History

TAMRO Capital Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-37,812	Closed	-$896K	–	70
2015 Q3	$896K	Sell	37,812 -39,024	-51%	-$942K	0.1%	63
2015 Q2	$1.82M	Sell	76,836 -3,234	-4%	-$73K	0.16%	72
2015 Q1	$1.9M	Sell	80,070 -16,350	-17%	-$367K	0.13%	70
2014 Q4	$2.05M	Sell	96,420 -33,030	-26%	-$664K	0.14%	72
2014 Q3	$2.2M	Sell	129,450 -11,934	-8%	-$188K	0.15%	68
2014 Q2	$2.02M	Sell	141,384 -44,430	-24%	-$602K	0.1%	81
2014 Q1	$2.3M	Buy	185,814 +16,278	+10%	+$188K	0.1%	71
2013 Q4	$1.86M	Sell	169,536 -31,380	-16%	-$354K	0.08%	92
2013 Q3	$2.33M	Sell	200,916 -8,610	-4%	-$101K	0.1%	80
2013 Q2	$2.35M	Buy	+209,526	New	+$2.48M	0.1%	77

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

TAMRO Capital Partners's EW Position: Q4 2015 in Review

TAMRO Capital Partners sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 37,812 shares — an estimated $896K sold.

TAMRO Capital Partners first reported a position in EW in Q2 2013 and held it in 10 quarters. The position peaked at $2.35M in Q2 2013. 604 funds tracked by Wall St. Rank hold EW as of Q4 2015.

TAMRO Capital Partners reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
TAMRO Capital Partners sold 37,812 Edwards Lifesciences shares in Q4 2015, an estimated $896K.
TAMRO Capital Partners first reported a position in Edwards Lifesciences in Q2 2013 and held it in 10 quarters.
TAMRO Capital Partners's Edwards Lifesciences position peaked at $2.35M in Q2 2013.
604 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on TAMRO Capital Partners's 13F filing for Q4 2015, filed 21 Jan 2016.